Market Closed -
Other stock markets
|
After market 13:21:59 | |||
6.11 EUR | +7.19% | 6.103 | -0.11% |
05-22 | Nanobiotix: strategy update, share price declines | CF |
05-21 | Nanobiotix to Transfer Phase 3 Head and Neck Cancer Study Sponsorship | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.98% | 291M | |
+64.31% | 62.59B | |
-1.29% | 41.18B | |
+44.76% | 40.29B | |
-8.93% | 27.9B | |
+13.40% | 26.21B | |
-21.87% | 19.09B | |
+4.98% | 13.08B | |
+25.29% | 12.26B | |
+28.12% | 12.05B |
- Stock Market
- Equities
- NANO Stock
- News Nanobiotix
- Nanobiotix Appoints Kayitalire as Chief Medical Officer